INBX
Inhibrx Biosciences Inc.
$106.85
+$5.53(+5.46%)
52
Overall
40
Value
63
Tech
55
Quality
Market Cap
$1.17B
Volume
228.81K
52W Range
$12.68 - $155.29
Target Price
$277.50
EPS Estimates Overview
| Current Quarter | $-2.5 | Next Quarter | $-2.7 |
| Current Year | $-10.15 | Next Year | $-7.67 |
| QoQ Growth | -8.0% | YoY Growth | +24.4% |
| 3Y EPS CAGR | +33.6% | Target Price | $277.50 |
| Consensus | Buy | Upside | +159.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INBX | $106.85 | +5.5% | 228.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inhibrx Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW